Published in BMC Complement Altern Med on August 31, 2016
Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol (2009) 4.63
IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J Immunol (2011) 1.92
The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Invest Dermatol (2012) 1.71
New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biol (2014) 1.53
Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis (2001) 1.48
Psoriasis: evolving treatment for a complex disease. Cleve Clin J Med (2012) 1.45
Similarities in coronary function and myocardial deformation between psoriasis and coronary artery disease: the role of oxidative stress and inflammation. Can J Cardiol (2014) 1.42
Inhibition of UVB-induced skin tumor development by drinking green tea polyphenols is mediated through DNA repair and subsequent inhibition of inflammation. J Invest Dermatol (2008) 1.29
Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases. Br J Clin Pharmacol (2012) 1.28
Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis. Immunology (2014) 1.25
Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. Proc Natl Acad Sci U S A (2009) 1.19
The roles of cells and cytokines in the pathogenesis of psoriasis. Int J Dermatol (2012) 1.14
Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor. J Mol Signal (2008) 1.13
Comparative studies on the physicochemical and antioxidant properties of different tea extracts. J Food Sci Technol (2011) 1.06
Green tea polyphenol induces caspase 14 in epidermal keratinocytes via MAPK pathways and reduces psoriasiform lesions in the flaky skin mouse model. Exp Dermatol (2007) 0.97
Interleukin-22: a likely target for treatment of autoimmune diseases. Autoimmun Rev (2014) 0.97
Novel approaches to chemoprevention of skin cancer. J Dermatol (2000) 0.96
Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice. PLoS One (2013) 0.96
Caspase-14-deficient mice are more prone to the development of parakeratosis. J Invest Dermatol (2012) 0.94
IL-19 is a component of the pathogenetic IL-23/IL-17 cascade in psoriasis. J Invest Dermatol (2014) 0.94
Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas. J Ocul Pharmacol Ther (2010) 0.93
IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms. Proc Natl Acad Sci U S A (2014) 0.92
Promising new treatments for psoriasis. ScientificWorldJournal (2013) 0.91
Reviewing concepts in the immunopathogenesis of psoriasis. An Bras Dermatol (2012) 0.91
Green tea polyphenols provide photoprotection, increase microcirculation, and modulate skin properties of women. J Nutr (2011) 0.90
Specific roles for dendritic cell subsets during initiation and progression of psoriasis. EMBO Mol Med (2014) 0.89
Reactive oxygen species prevent imiquimod-induced psoriatic dermatitis through enhancing regulatory T cell function. PLoS One (2014) 0.86
Insights on the formulation of herbal beverages with medicinal claims according with their antioxidant properties. Molecules (2013) 0.85
Role of cellular oxidative stress and cytochrome c in the pathogenesis of psoriasis. Arch Dermatol Res (2012) 0.83
Phototherapy in psoriasis: a review of mechanisms of action. J Cutan Med Surg (2013) 0.83
Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1β secretion. Biochem Biophys Res Commun (2011) 0.83
IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions. J Invest Dermatol (2013) 0.83
Comparison of topical 3% diclofenac sodium gel and 5% imiquimod cream for the treatment of actinic keratoses. Clin Exp Dermatol (2011) 0.82
Polyphenon-60 displays a therapeutic effect on acne by suppression of TLR2 and IL-8 expression via down-regulating the ERK1/2 pathway. Arch Dermatol Res (2012) 0.81
Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis. Mol Med Rep (2014) 0.81
Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis. Clin Cosmet Investig Dermatol (2013) 0.81
Assessment of an imiquimod-induced psoriatic mouse model in relation to oxidative stress. Arch Dermatol Res (2012) 0.80
Protective mechanisms of green tea polyphenols in skin. Oxid Med Cell Longev (2012) 0.80
Topical application of delphinidin reduces psoriasiform lesions in the flaky skin mouse model by inducing epidermal differentiation and inhibiting inflammation. Br J Dermatol (2014) 0.78